CD45
Showing 1 - 25 of 4,491
Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))
Recruiting
- Hematologic Malignancy
- CD45RA depleted donor lymphocyte infusion (DLI)
-
Tuebingen,, Germany
- +1 more
Jul 13, 2023
Acute Leukemia, Acute Myeloid Leukemia, MDS Trial in Philadelphia (CliniMACS Cell Processing System for TCRaß + T Cell and
Recruiting
- Acute Leukemia
- +7 more
- CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 21, 2022
Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using
Recruiting
- Relapsed Pediatric ALL
- +2 more
- In Vitro T cells depletion using CliniMCAS system
-
Shanghai, ChinaShanghai Children's Medical Center
Sep 28, 2022
Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)
Recruiting
- Non-Malignant Neoplasm
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Hematologic Malignancy, Haplo-identical Stem Cell Transplantation Trial (CD45RAneg cells, prepared from mononuclear cell
Not yet recruiting
- Hematologic Malignancy
- Haplo-identical Stem Cell Transplantation
- CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology
- (no location specified)
Oct 1, 2021
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Severe Combined Immunodeficiency Trial in Memphis (drug, device, other)
Recruiting
- Severe Combined Immunodeficiency
- Anti-thymocyte globulin (rabbit)
- +5 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 6, 2021
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid
Recruiting
- Acute Lymphoblastic Leukemia in Remission
- +11 more
- Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 24, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)
Suspended
- Acute Myeloid Leukemia
- +4 more
- CD8+ Memory T Cell Infusion
- +5 more
-
Stanford, CaliforniaStanford Medical Center
Sep 23, 2021
Bone Marrow Transplant Infection, Bone Marrow Transplant Complications, Graft Vs Host Disease Trial in Rozzano (modified donor
Completed
- Bone Marrow Transplant Infection
- +4 more
- modified donor lymphocytes infusion (mDLI)
-
Rozzano, MI, ItalyIstituto Clinico Humanitas
Dec 24, 2020
Cellular Population CD45+ Infiltrating Human Glioblastoma
Completed
- Glioblastoma
- no intervention
-
Amiens, FranceCHU Amiens-Picardie
Jul 15, 2020
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult
Terminated
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +9 more
- Allogeneic Bone Marrow Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 4, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia
Recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Cyclosporine
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Ewing Sarcoma, Gastrointestinal Tumor, Germ Cell Tumor Trial in Memphis (drug, biological, device)
Completed
- Ewing Sarcoma
- +12 more
- alemtuzumab
- +6 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 14, 2020
GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)
Terminated
- Graft Versus Host Disease
- +2 more
- Fludarabine Phosphate
- +7 more
-
New Haven, Connecticut
- +1 more
Aug 10, 2020
Leukemia, Lymphoma, MDS Trial in Moscow (CD45RA-depleted peripheral blood mononuclear cells)
Unknown status
- Leukemia
- +5 more
- CD45RA-depleted peripheral blood mononuclear cells
-
Moscow, Russian FederationFederal Research Center for pediatric hematology, oncology and i
Feb 5, 2020
End-stage Renal Disease Trial (Blood samples)
Not yet recruiting
- End-stage Renal Disease
- Blood samples
- (no location specified)
Jan 28, 2020
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma Trial in Seattle (procedure,
Completed
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 29, 2020
Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (procedure, drug, radiation)
Completed
- Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Allogeneic Hematopoietic Stem Cell Transplantation
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 6, 2019
DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab
Recruiting
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
- +7 more
-
Birmingham, Alabama
- +61 more
Apr 13, 2022
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic
Recruiting
- Diabetes Complications
- Diabetic Retinopathy
- Generation of inducible pluripotent stem cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
May 17, 2022